Literature DB >> 31593321

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.

Oreofe O Odejide1,2, Hajime Uno1, Anays Murillo3, James A Tulsky4,5, Gregory A Abel1,6.   

Abstract

BACKGROUND: Patients with blood cancers experience high-intensity medical care near the end of life (EOL) and low rates of hospice use; attributes of goals of care (GOC) discussions may partly explain these outcomes.
METHODS: By using a retrospective cohort of patients with blood cancer who received care at Dana-Farber Cancer Institute and died in 2014, the authors assessed the potential relationship between timing, location, and the involvement of hematologic oncologists in the first GOC discussion with intensity of care near the EOL and timely hospice use.
RESULTS: Among 383 patients, 39.2% had leukemia/myelodysplastic syndromes, 37.1% had lymphoma, and 23.7% had myeloma. Overall, 65.3% of patients had a documented GOC discussion. Of the first discussions, 33.2% occurred >30 days before death, 34.8% occurred in the outpatient setting, and 46.4% included a hematologic oncologist. In multivariable analyses, having the first discussion >30 days before death (odds ratio [OR], 0.37; 95% CI, 0.17-0.81), in the outpatient setting (OR, 0.21; 95% CI, 0.09-0.50), and having a hematologic oncologist present (OR, 0.40; 95% CI, 0.21-0.77) were associated with lower odds of intensive care unit admission ≤30 days before death. The presence of a hematologic oncologist at the first discussion (OR, 3.07; 95% CI, 1.58-5.96) also was associated with earlier hospice use (>3 days before death).
CONCLUSIONS: In this large cohort of blood cancer decedents, most initial GOC discussions occurred close to death and in the inpatient setting. When discussions were timely, outpatient, or involved hematologic oncologists, patients were less likely to experience intensive health care use near death and were more likely to enroll in hospice.
© 2019 American Cancer Society.

Entities:  

Keywords:  blood cancers; end-of-life care; goals of care discussions; hematologic oncologists

Mesh:

Year:  2019        PMID: 31593321      PMCID: PMC6980246          DOI: 10.1002/cncr.32549

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  End-of-life care discussions among patients with advanced cancer: a cohort study.

Authors:  Jennifer W Mack; Angel Cronin; Nathan Taback; Haiden A Huskamp; Nancy L Keating; Jennifer L Malin; Craig C Earle; Jane C Weeks
Journal:  Ann Intern Med       Date:  2012-02-07       Impact factor: 25.391

2.  Patterns of hospice use in patients dying from hematologic malignancies.

Authors:  Amy Sexauer; M Jennifer Cheng; Louise Knight; Anthony W Riley; Lauren King; Thomas J Smith
Journal:  J Palliat Med       Date:  2014-01-02       Impact factor: 2.947

3.  NCCN Guidelines Insights: Palliative Care, Version 2.2017.

Authors:  Maria Dans; Thomas Smith; Anthony Back; Justin N Baker; Jessica R Bauman; Anna C Beck; Susan Block; Toby Campbell; Amy A Case; Shalini Dalal; Howard Edwards; Thomas R Fitch; Jennifer Kapo; Jean S Kutner; Elizabeth Kvale; Charles Miller; Sumathi Misra; William Mitchell; Diane G Portman; David Spiegel; Linda Sutton; Eytan Szmuilowicz; Jennifer Temel; Roma Tickoo; Susan G Urba; Elizabeth Weinstein; Finly Zachariah; Mary Anne Bergman; Jillian L Scavone
Journal:  J Natl Compr Canc Netw       Date:  2017-08       Impact factor: 11.908

4.  Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

Authors:  Oreofe O Odejide; Angel M Cronin; Craig C Earle; Ann S LaCasce; Gregory A Abel
Journal:  J Natl Cancer Inst       Date:  2015-10-05       Impact factor: 13.506

5.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

6.  Trends in Advance Care Planning in Patients With Cancer: Results From a National Longitudinal Survey.

Authors:  Amol K Narang; Alexi A Wright; Lauren H Nicholas
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

7.  End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences.

Authors:  Jennifer W Mack; Jane C Weeks; Alexi A Wright; Susan D Block; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

8.  Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study.

Authors:  David Hui; Neha Didwaniya; Marieberta Vidal; Seong Hoon Shin; Gary Chisholm; Joyce Roquemore; Eduardo Bruera
Journal:  Cancer       Date:  2014-02-18       Impact factor: 6.860

Review 9.  Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?

Authors:  Craig C Earle; Mary Beth Landrum; Jeffrey M Souza; Bridget A Neville; Jane C Weeks; John Z Ayanian
Journal:  J Clin Oncol       Date:  2008-08-10       Impact factor: 44.544

Review 10.  Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.

Authors:  Timothy Gilligan; Nessa Coyle; Richard M Frankel; Donna L Berry; Kari Bohlke; Ronald M Epstein; Esme Finlay; Vicki A Jackson; Christopher S Lathan; Charles L Loprinzi; Lynne H Nguyen; Carole Seigel; Walter F Baile
Journal:  J Clin Oncol       Date:  2017-09-11       Impact factor: 44.544

View more
  11 in total

1.  Goals of care discussions: perceptions of radiation and medical oncologists.

Authors:  Daniel Hong; Lauren C Das; Ellen Daily; Stacie K Levine; Olwen M Hahn; Stanley L Liauw; Daniel W Golden; Christina H Son
Journal:  Support Care Cancer       Date:  2021-05-25       Impact factor: 3.603

Review 2.  Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas.

Authors:  Oreofe O Odejide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes.

Authors:  Andrew S Epstein; Michael Riley; Judith E Nelson; Camila Bernal; Steven Martin; Han Xiao
Journal:  Cancer       Date:  2022-07-22       Impact factor: 6.921

4.  Correlates of common concerns in older cancer survivors of leukemia and lymphoma: results from the WHI LILAC study.

Authors:  Kah Poh Loh; Eric M McLaughlin; Jessica L Krok-Schoen; Oreofe O Odejide; Areej El-Jawahri; Lihong Qi; Aladdin H Shadyab; Lisa G Johnson; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2022-08-18       Impact factor: 4.062

5.  Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies.

Authors:  Clark DuMontier; Hajime Uno; Tammy Hshieh; Guohai Zhou; Richard Chen; Emily S Magnavita; Lee Mozessohn; Houman Javedan; Richard M Stone; Robert J Soiffer; Jane A Driver; Gregory A Abel
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047

6.  End-of-Life Care for Older Adults with Aggressive Non-Hodgkin Lymphoma.

Authors:  P Connor Johnson; Netana H Markovitz; Alisha Yi; Richard A Newcomb; Hermioni L Amonoo; Ashley M Nelson; Matthew J Reynolds; Julia Rice; Mitchell W Lavoie; Oreofe O Odejide; Ryan D Nipp; Areej El-Jawahri
Journal:  J Palliat Med       Date:  2021-11-01       Impact factor: 2.947

Review 7.  Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?

Authors:  Thomas M Kuczmarski; Oreofe O Odejide
Journal:  Curr Hematol Malig Rep       Date:  2021-04-16       Impact factor: 3.952

8.  Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study.

Authors:  Keyi Wang; Weipu Mao; Heng Shi; Guangchun Wang; Lei Yin; Jinbo Xie; Lap Hong Ian; Hui Zhang; Bo Peng
Journal:  Transl Androl Urol       Date:  2020-08

9.  A Cross-Sectional Analysis of Ambulatory Oncology Experience by Treatment Intent.

Authors:  Linda Watson; Siwei Qi; Eclair Photitai; Andrea DeIure
Journal:  Curr Oncol       Date:  2020-12-18       Impact factor: 3.677

10.  Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Marissa LoCastro; Andrea M Baran; Jane L Liesveld; Eric Huselton; Michael W Becker; Kristen Marie O'Dwyer; Omar S Aljitawi; Megan Baumgart; Eric Snyder; Benzi Kluger; Kah Poh Loh; Jason H Mendler
Journal:  Blood Adv       Date:  2021-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.